Corbus Pharmaceuticals Holding Inc. buy BiotechBee
Start price
15.04.24
/
70%
€38.80
Target price
30.06.26
€50.00
Performance (%)
-62.37%
End price
14.12.24
€14.60
Summary
This prediction ended on 14.12.24 with a price of €14.60. Massive losses of -62.37% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corbus Pharmaceuticals Holding Inc. | -3.974% | -3.974% | -21.622% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
According to BiotechBee what are the pros and cons of Corbus Pharmaceuticals Holding Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Corbus Pharmaceuticals Holdings Inc diskutieren
Buy mit Kursziel 50,0